TRPA1

Across TCGA pan-cancer cohorts, TRPA1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TRPA1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TRPA1 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated TRPA1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and COAD are the cancer types where TRPA1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	0.953	0.312	.002	36	view →
COAD	OS	Median	IV	0.045	0.659	<.001	17	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TRPA1–UCEC (OS)

Open the UCEC breakdown →